Our weekly round-up of the bright young things and big cheeses in pharmaceuticals.
Former GSK executive Agnes Westelinck has announced she will join regulatory consultancy NDA Partners as a Premier Expert Consultant.
Westelinck was Executive Director and Global Head of Regulatory Affairs for Oncology at GlaxoSmithKline from 2010 to 2014. She previously worked in regulation for Hoffman-La Roche, Barrier Therapeutics, Schering-Plough, Fournier Pharma and UCB.
As a consultant for NDA Partners Westelinck will advise clients developing medical products about regulatory pathways and access to global markets, and help make their companies attractive to investors.
The 40-strong strategy consultancy began in 2003 advising emerging pharmaceuticals companies and life sciences investment funds, and now works with pharma multinationals entering the US market as well as R&D-oriented government agencies.
Copyright - Unless otherwise stated all contents of this web site are © 2017 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
Welcome to in-PharmaTechnologist's monthly round up of who's been moving where in the small-molecule manufacturing world. The...
Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the...
The world’s largest modular cGMP biopharmaceutical manufacturing facility came online this week in Wuhan, China.
Valeant, Rentschler, Celgene, MannKind, and Syngene are among those welcoming new leaders for 2016. Oh, and Turing...